In a breakthrough discovery, researchers in Brazil have detected cannabidiol (CBD)—a prominent compound commonly associated with cannabis—in a non-cannabis plant, opening the door to potentially simpler and more accessible methods of production.
Scientists analyzing Trema micrantha blume, a shrub prevalent across South America and often dismissed as a weed, confirmed the presence of CBD within its fruits and flowers—remarkably, without any detectable levels of tetrahydrocannabinol (THC), the psychoactive component of cannabis. ScienceAlert+1
CBD, widely recognized for its therapeutic potential in managing epilepsy, chronic pain, and anxiety, continues to be the subject of vigorous scientific investigation. ScienceAlert+1 The apparent absence of THC in Trema offers a notable advantage, as it may alleviate the regulatory and legal complexities tied to cannabis cultivation and extraction. “It’s a legal alternative to using cannabis,” affirmed molecular biologist Rodrigo Moura Neto of the Federal University of Rio de Janeiro. ScienceAlert+1
Dr. Neto revealed that earlier research had detected CBD in a related Thai shrub, but the Brazilian discovery presents a potentially more practical and abundant source. ScienceAlert+1
Looking forward, Neto’s team plans to scale up the study—focusing on optimizing extraction methods and evaluating the therapeutic effectiveness of Trema-derived CBD in medical settings. The initiative has been awarded a grant of 500,000 Brazilian reals (approximately US $104,000), with an anticipated timeline of at least five years for comprehensive research. ScienceAlert+1
Key Highlights at a Glance
| Aspect | Details |
|---|---|
| Plant | Trema micrantha blume, a common shrub in South America |
| Compound Identified | CBD (cannabidiol), without THC |
| Significance | Potential legal and less complex source of CBD |
| Research Timeline | Minimum 5 years, funded by 500,000 reals (~US $104k) |
| Future Steps | Develop extraction protocols; assess medical efficacy |
This revelation offers a promising alternative to hemp-derived CBD by potentially sidestepping stringent cannabis-related regulation and associated costs. As research progresses, it may pave the way for new agricultural and therapeutic practices—assuming Trema-derived CBD proves both effective and scalable in clinical applications.
Dabbin-Dad
